15
Participants
Start Date
August 23, 2011
Primary Completion Date
December 13, 2012
Study Completion Date
May 26, 2015
FOLFIRINOX, IPI-926
"Oxaliplatin: intravenous, 50 to 85 mg/m2, over 2 hrs, once per cycle.~Leucovorin: intravenous, 400 mg/m2, over 2 hrs, once per cycle.~Irinotecan: intravenous, 120 to 180 mg/m2, over 90 minutes, once per cycle.~5-FU: intravenous, 1600 to 2400mg/m2, over 46hr continuous infusion, once per cycle.~IPI-926: oral, 130 to 160 mg/day, daily, 14 days per cycle."
University of Wisconsin Comprehensive Cancer Center, Madison
University of Chicago Comprehensive Cancer Center, Chicago
UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
Collaborators (1)
Infinity Pharmaceuticals, Inc.
INDUSTRY
Andrew Ko
OTHER